 - Histologically or cytologically confirmed hepatocellular carcinoma HCC. histology or cytology from prior tumor biopsy specimen is acceptable. For Part 1 continuous dosing regimen and Part 2, HCC participants must have fibroblast growth factor FGF 19 amplification based on central laboratory results 